GLP-1s, a class of drugs used to treat type 2 diabetes, obesity, cardiovascular disease, and other conditions, have exploded in popularity in recent years due to their demonstrated effectiveness, but are often not covered by insurance, particularly for the treatment of obesity
This specific prebiotic inhibits DPP-IV enzyme activity, extending the lifespan of GLP-1 for prolonged effects on glucose regulation and hunger suppression.*
Ultimately, lasting weight management requires honest evaluation of your health history, your relationship with food, and your readiness for change
Efficacy of coenzyme Q10 in migraine prophylaxis: a randomized controlled trial
Conversely, we found little evidence that GLP-1RAs may cause or exacerbate cognitive impairment, which is of importance to patients who may need to take these medications for their currently licensed (and expanding) indications